§ Federal grant opportunity · PAR-27-053
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health is accepting applications for Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional). The deadline is June 16, 2028 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- June 16, 2028
- Award range
- Award amount not published
- Eligibility
- for profit organizations other than small businesses, small businesses, private institutions of higher education, public and indian housing authorities, special district governments, city or township governments, other, public and state institutions of higher education, nonprofits non higher education without 501c3, other native american tribal organizations, state governments, independent school districts, federally recognized native american tribal governments, nonprofits non higher education with 501c3, county governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-27-053
Program overview
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activity code (e.g., PA-25-305 "Research Project Grant (Parent R01 Clinical Trial Required)" or its subsequent reissue).
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before June 16, 2028, allowing time for registration and validation.
Related grant opportunities
- BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed)
- Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
- Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
- Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.